Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021474
Filing Date
2023-05-12
Accepted
2023-05-12 06:02:53
Documents
80
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tbio-20230331.htm   iXBRL 10-Q 2799362
2 EX-21.1 tbio-ex21_1.htm EX-21.1 7771
3 EX-31.1 tbio-ex31_1.htm EX-31.1 17602
4 EX-32.1 tbio-ex32_1.htm EX-32.1 10638
  Complete submission text file 0000950170-23-021474.txt   10581783

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tbio-20230331_pre.xml EX-101.PRE 395394
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tbio-20230331.xsd EX-101.SCH 49181
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tbio-20230331_lab.xml EX-101.LAB 525336
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tbio-20230331_def.xml EX-101.DEF 217205
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tbio-20230331_cal.xml EX-101.CAL 76207
74 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20230331_htm.xml XML 2144145
Mailing Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121
Business Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40497 | Film No.: 23913011
SIC: 3826 Laboratory Analytical Instruments